HOME >> BIOLOGY >> NEWS
Hamburger disease drug put to the test

A research study, testing a new treatment for hamburger disease, was launched today at The Montreal Children's Hospital of the McGill University Health Centre (MUHC). The study conducted by investigators from the Research Institute of the MUHC and from The Children's, will test the ability of this treatment to stop disease progression in children.

"Hamburger disease", or hemolytic uremic syndrome (HUS), affects more than 3 000 North Americans annually and is one the leading causes of acute and chronic kidney failure in children. It usually occurs following a gastrointestinal infection caused by a strain of bacteria called E.coli O157:H7. This bacterium has been associated with eating undercooked ground beef and drinking contaminated water, unpasteurized milk, or apple juice. The organism was involved in the Walkerton epidemic several years ago.

"Currently, there is no effective treatment for HUS," says MUHC pediatrician and lead investigator Dr. Paul Goodyer. "Approximately, ten percent of E.coli-infected patients, many of whom are children, develop HUS. About half of the HUS patients require dialysis and even with comprehensive medical care four to five percent of these patients will die. Thirty percent to fifty percent of the survivors will develop long-term complications such as chronic kidney disease and nervous system disorders. Clearly, we need treatment for this disease."

The MUHC is one of six Canadian centres testing this new treatment. The treatment involves administrating an antibody to the toxin produced by E.coli O157:H7. "We expect that this antibody will inactivate the toxin in the bloodstream at an early enough stage to prevent damage to kidneys and brain," says MUHC emergency room physician and co-investigator Dr. Dominic Chalut.

Children seen at the Montreal Children's Hospital Emergency Department who have bloody diarrhea for less than 72 hours and whose stools test positive for E.coli O157:H7 are eligible for t
'"/>

Contact: Christine Zeindler
christine.zeindler@muhc.mcgill.ca
514-934-1934
McGill University
29-Jul-2003


Page: 1 2

Related biology news :

1. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
2. Alzheimers disease is not accelerated aging
3. New molecular link key to cellular proteins involved in cancer progression, other diseases
4. Wildlife Conservation Society hosts public symposium on human-wildlife diseases
5. University of Alberta researcher looks for clues to mysterious disease
6. Study explores gene transfer to modify underlying course of Alzheimers disease
7. Experimental drug shown to block mutant protein causing blood disease
8. Algal contact as a trigger for coral disease
9. Ecology of infectious diseases grants awarded
10. Venn diagram tactics to vet complex disease
11. Genetically modified bacterium as remedy for intestinal diseases

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: